Udg Healthcare PLC (LON:UDG) has been assigned a consensus rating of “Hold” from the seven research firms that are covering the company, Marketbeat reports. One analyst has rated the stock with a sell rating and six have assigned a hold rating to the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is GBX 824 ($11.09).
A number of research firms have weighed in on UDG. Peel Hunt restated an “add” rating and issued a GBX 860 ($11.57) target price on shares of Udg Healthcare in a research report on Tuesday, November 28th. N+1 Singer restated a “hold” rating on shares of Udg Healthcare in a research report on Tuesday, November 28th. Liberum Capital restated a “hold” rating and issued a GBX 884 ($11.90) target price on shares of Udg Healthcare in a research report on Wednesday, November 15th. Jefferies Group upped their target price on Udg Healthcare from GBX 830 ($11.17) to GBX 855 ($11.51) and gave the stock a “hold” rating in a research report on Wednesday, October 4th. Finally, Numis Securities downgraded Udg Healthcare to a “reduce” rating and set a GBX 765 ($10.30) target price for the company. in a research report on Thursday, November 9th.
Shares of Udg Healthcare (LON:UDG) remained flat at $GBX 848 ($11.41) during mid-day trading on Friday. The company’s stock had a trading volume of 88,961 shares, compared to its average volume of 782,715. Udg Healthcare has a 12-month low of GBX 632.50 ($8.51) and a 12-month high of GBX 963 ($12.96).
The business also recently disclosed a dividend, which will be paid on Monday, February 5th. Stockholders of record on Thursday, January 11th will be given a dividend of $0.10 per share. This represents a dividend yield of 0.84%. The ex-dividend date of this dividend is Thursday, January 11th. This is an increase from Udg Healthcare’s previous dividend of $0.04.
Udg Healthcare Company Profile
UDG Healthcare plc, formerly United Drug plc, is a healthcare services provider in the Republic of Ireland, the United Kingdom, North America and Continental Europe. The Company operates in three segments. The Ashfield Commercial & Medical Services segment is engaged in the provision of sales, marketing and healthcare communications services to pharmaceutical companies, and it also provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to over 300 healthcare companies.
Receive News & Ratings for Udg Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.